Blog Posts

Eric Miller from The James leads Alliance for Clinical Trials in Oncology A022101/ERASur

Photo taken from Alliance for Clinical Trials in Oncology/X

Aug 11, 2024, 12:10

Eric Miller from The James leads Alliance for Clinical Trials in Oncology A022101/ERASur

Alliance for Clinical Trials in Oncology shared a post on X:

“In case you missed it.

Eric Miller from The James leads Alliance for Clinical Trials in Oncology A022101/ERASur, a trial for patients with metastatic colorectal cancer that compares total ablative therapy and usual systemic therapy to usual systemic therapy alone.”

Additional information
Source: Alliance for Clinical Trials in Oncology/X

A022101/ERASur ablative therapy Alliance for Clinical Trials in Oncology cancer Eric Miller Metastatic colorectal cancer OncoDaily Oncology systemic therapy The James

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC